ConductScience.org, home

Paper3650100

Neutralizing antibodies and the course of HIV-induced disease.

Wendler I and 2 others. AIDS Res Hum Retroviruses, 1987. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Neutralizing antibodies and the course of HIV-induced disease. Papers, record 3650100. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3650100

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neutralizing antibodies and the course of HIV-induced disease.
PubMed
Journal
AIDS Res Hum Retroviruses
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
1.38
iCite
Revised in PubMed
2006-11-15
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wendler II
2Bienzle UU
3Hunsmann GG

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AIDS-Related ComplexMajor topic
Acquired Immunodeficiency SyndromeMajor topic
Antibodies, ViralMajor topic
HIVMajor topic
Cytopathogenic Effect, Viral
Humans
Neutralization Tests
Viral Envelope Proteins

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
18197170The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.Nat Rev Microbiol2008https://conductscience.org/library/papers/18197170PubMed
9371609Identification of the V1 region as a linear neutralizing epitope of the simian immunodeficiency virus SIVmac envelope glycoprotein.J Virol1997https://conductscience.org/library/papers/9371609PubMed
9060635Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1.J Virol1997https://conductscience.org/library/papers/9060635PubMed
8464405Pathogenesis of human immunodeficiency virus infection.Microbiol Rev1993https://conductscience.org/library/papers/8464405PubMed
8394444Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue.J Virol1993https://conductscience.org/library/papers/8394444PubMed
8107199Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.J Virol1994https://conductscience.org/library/papers/8107199PubMed
7583913Presence of neutralizing antibodies to heterologous human immunodeficiency virus type 1 isolates in sera of infected individuals is not predictive of rate of disease progression.Clin Diagn Lab Immunol1995https://conductscience.org/library/papers/7583913PubMed
3282628Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.CMAJ1988https://conductscience.org/library/papers/3282628PubMed
3208445Neutralizing antibodies in relation to antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus type I.Clin Exp Immunol1988https://conductscience.org/library/papers/3208445PubMed
3172340Simian immunodeficiency virus from African green monkeys.J Virol1988https://conductscience.org/library/papers/3172340PubMed
2479014Presence of maternal antibodies to human immunodeficiency virus 1 envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers.Proc Natl Acad Sci U S A1989https://conductscience.org/library/papers/2479014PubMed
2462060Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping.J Virol1989https://conductscience.org/library/papers/2462060PubMed
1901833Serological markers as prognostic criteria for the course of HIV infection.Infection1991https://conductscience.org/library/papers/1901833PubMed
1696634Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.J Virol1990https://conductscience.org/library/papers/1696634PubMed
1601999Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.J Clin Invest1992https://conductscience.org/library/papers/1601999PubMed
1572084B cell responses to HIV and the development of human monoclonal antibodies.Clin Exp Immunol1992https://conductscience.org/library/papers/1572084PubMed
1370558Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120.J Virol1992https://conductscience.org/library/papers/1370558PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3650100

GET https://conductscience.org/api/papers/v1/3650100/authors